These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36756220)

  • 1. Primary Cutaneous T-Cell/Histiocyte-Rich B-Cell Lymphoma: A Case Report and Literature Review.
    Al Harbi SM; Al Ghamdi NJ; Elsharkawy TM; Al Hamad MA; Bajawi S
    Clin Cosmet Investig Dermatol; 2023; 16():309-316. PubMed ID: 36756220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature.
    Vezzoli P; Fiorani R; Girgenti V; Fanoni D; Tavecchio S; Balice Y; Mozzana R; Crosti C; Berti E
    Dermatology; 2011; 222(3):225-30. PubMed ID: 21540569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting.
    Glynn E; Fromm JR
    Cytometry B Clin Cytom; 2020 Jan; 98(1):88-98. PubMed ID: 31254446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T Cell/Histiocyte-Rich Large B Cell Lymphoma of the Thymus: A Diagnostic Pitfall.
    Xu J; Wu X; Reddy V
    Case Rep Hematol; 2016; 2016():2942594. PubMed ID: 26904321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype.
    Hartmann S; Tousseyn T; Döring C; Flüchter P; Hackstein H; Herreman A; Ponzoni M; de Wolf-Peeters C; Facchetti F; Gascoyne RD; Küppers R; Steidl C; Hansmann ML
    Int J Cancer; 2013 Dec; 133(11):2609-18. PubMed ID: 23686423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of T cell/histiocyte-rich large B cell lymphoma misdiagnosed as lymphomatoid papulosis.
    Kim T; Kim J; Park J
    Medicine (Baltimore); 2023 Mar; 102(13):e33407. PubMed ID: 37000052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base.
    Ollila TA; Reagan JL; Olszewski AJ
    Leuk Lymphoma; 2019 Dec; 60(14):3426-3433. PubMed ID: 31287335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell/histiocyte-rich large B-cell lymphoma of the thyroid.
    Ichikawa S; Watanabe Y; Saito K; Kimura J; Ichinohasama R; Harigae H
    Exp Hematol Oncol; 2013 Jan; 2(1):1. PubMed ID: 23298413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: An Unusual Presentation of a Rare Disease and Literature Review.
    Conte GA; Harmon JS; Le ML; Sun X; Schuler JW; Levitt MJ; Chinnici AA; Hossain MA
    World J Oncol; 2019 Dec; 10(6):231-236. PubMed ID: 31921379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?
    Hartmann S; Döring C; Jakobus C; Rengstl B; Newrzela S; Tousseyn T; Sagaert X; Ponzoni M; Facchetti F; de Wolf-Peeters C; Steidl C; Gascoyne R; Küppers R; Hansmann ML
    PLoS One; 2013; 8(11):e78812. PubMed ID: 24244368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphoma.
    Schmitz C; Rekowski J; Reinke S; Müller SP; Hüttmann A; Klapper W; Dührsen U
    Leuk Lymphoma; 2020 Jun; 61(6):1372-1379. PubMed ID: 32022621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
    Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
    Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestinal presentation of nodular lymphocyte-predominant Hodgkin lymphoma with T cell/histiocyte-rich B cell lymphoma-like areas-with review of literature on extranodal presentation of this disease.
    Bagwan IN; Knee G; Abboudi Z; Naresh KN
    J Hematop; 2010 Mar; 3(1):29-34. PubMed ID: 21436871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP.
    Kim YS; Ji JH; Ko YH; Kim SJ; Kim WS
    Acta Haematol; 2014; 131(3):156-61. PubMed ID: 24192382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification.
    Tousseyn T; De Wolf-Peeters C
    Virchows Arch; 2011 Dec; 459(6):557-63. PubMed ID: 22081105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T Cell Histiocyte Rich Large B Cell Lymphoma Presenting as Hemophagocytic Lymphohistiocytosis: An Uncommon Presentation of a Rare Disease.
    Ibrahim U; Garcia G; Saqib A; Hussein S; Dai Q
    Case Rep Oncol Med; 2017; 2017():6428461. PubMed ID: 28912991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
    Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
    Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide.
    Siricilla M; Irwin L; Ferber A
    Case Rep Oncol Med; 2018; 2018():6137454. PubMed ID: 29552367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia.
    Kunder C; Cascio MJ; Bakke A; Venkataraman G; O'Malley DP; Ohgami RS
    Am J Clin Pathol; 2017 Jun; 147(6):596-603. PubMed ID: 28575178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade.
    Tabanelli V; Melle F; Motta G; Mazzara S; Fabbri M; Agostinelli C; Calleri A; Del Corvo M; Fiori S; Lorenzini D; Cesano A; Chiappella A; Vitolo U; Derenzini E; Griffin GK; Rodig SJ; Vanazzi A; Sabattini E; Tarella C; Sapienza MR; Pileri SA
    Blood Adv; 2022 Aug; 6(15):4634-4644. PubMed ID: 35767735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.